Further, a growing number of genes and their protein products involved in post-translational glycosylation pathways, in particular of α-dystroglycan, are responsible for human neuromuscular disorders and various forms of congenital muscular dystrophy [4]. The gene discussed is DAG1; the disease is congenital muscular dystrophy.